US Stock MarketDetailed Quotes

4D Molecular Therapeutics (FDMT)

Watchlist
  • 10.450
  • +0.110+1.06%
Close May 13 16:00 ET
  • 10.450
  • 0.0000.00%
Pre 04:53 ET
546.29MMarket Cap-4.07P/E (TTM)

4D Molecular Therapeutics (FDMT) Balance Sheet

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Assets
Current assets
Cash, cash equivalents and short term investments
21.61%390.89M
-5.23%402.66M
-5.23%402.66M
-39.22%305.06M
-45.89%293.23M
-38.88%321.44M
47.41%424.88M
47.41%424.88M
57.01%501.89M
74.63%541.95M
-Cash and cash equivalents
-45.71%72.49M
-59.66%60.24M
-59.66%60.24M
-74.11%48.56M
-59.19%77.16M
-51.55%133.53M
-40.05%149.34M
-40.05%149.34M
-31.97%187.54M
-19.99%189.06M
-Short-term investments
69.44%318.4M
24.27%342.41M
24.27%342.41M
-18.40%256.51M
-38.77%216.07M
-24.93%187.91M
604.28%275.54M
604.28%275.54M
614.67%314.35M
376.67%352.89M
Other current assets
30.04%14.47M
4.22%10.48M
4.22%10.48M
-17.50%7.31M
-5.85%10.06M
14.99%11.13M
20.33%10.06M
20.33%10.06M
3.33%8.87M
43.78%10.69M
Total current assets
21.89%405.36M
-5.01%413.13M
-5.01%413.13M
-38.84%312.38M
-45.12%303.29M
-37.91%332.57M
46.65%434.93M
46.65%434.93M
55.60%510.76M
73.91%552.63M
Non current assets
Net PPE
-20.89%30.94M
-18.71%33.01M
-18.71%33.01M
-15.78%35.06M
26.16%37.15M
27.91%39.12M
28.24%40.61M
28.24%40.61M
27.35%41.63M
-12.48%29.45M
-Gross PPE
-5.74%53.49M
-5.08%54.29M
-5.08%54.29M
-3.49%55.12M
27.90%55.96M
29.90%56.75M
31.19%57.19M
31.19%57.19M
31.25%57.12M
0.61%43.75M
-Accumulated depreciation
-27.86%-22.55M
-28.30%-21.28M
-28.30%-21.28M
-29.52%-20.06M
-31.48%-18.8M
-34.56%-17.64M
-39.00%-16.59M
-39.00%-16.59M
-43.02%-15.49M
-45.38%-14.3M
Investments and advances
-51.29%66.74M
38.22%111.38M
38.22%111.38M
37.69%67.17M
246.65%123.81M
117.67%137M
635.65%80.58M
635.65%80.58M
--48.78M
--35.72M
Other non current assets
39.97%9.86M
115.63%9.19M
115.63%9.19M
227.51%9.38M
304.74%9.39M
813.49%7.04M
522.95%4.26M
522.95%4.26M
319.94%2.86M
114.81%2.32M
Total non current assets
-41.29%107.54M
22.42%153.58M
22.42%153.58M
19.66%111.61M
152.43%170.35M
94.24%183.16M
189.71%125.45M
189.71%125.45M
179.51%93.27M
94.33%67.48M
Total assets
-0.55%512.91M
1.13%566.71M
1.13%566.71M
-29.81%423.98M
-23.62%473.64M
-18.12%515.73M
64.87%560.38M
64.87%560.38M
67.04%604.03M
75.92%620.12M
Liabilities
Current liabilities
Payables
253.94%14.69M
154.42%11.16M
154.42%11.16M
134.71%6.86M
153.57%8.7M
-1.57%4.15M
24.78%4.39M
24.78%4.39M
-37.96%2.92M
-1.77%3.43M
-accounts payable
253.94%14.69M
154.42%11.16M
154.42%11.16M
134.71%6.86M
153.57%8.7M
-1.57%4.15M
24.78%4.39M
24.78%4.39M
-37.96%2.92M
-1.77%3.43M
Current accrued expenses
41.12%22.87M
42.42%26.87M
42.42%26.87M
12.95%24.19M
50.20%19.19M
79.77%16.2M
57.06%18.87M
57.06%18.87M
110.07%21.42M
94.25%12.78M
Current debt and capital lease obligation
-3.40%5.49M
-0.80%5.59M
-0.80%5.59M
11.86%5.7M
79.01%5.72M
78.98%5.68M
79.01%5.64M
79.01%5.64M
62.86%5.09M
3.00%3.2M
-Current capital lease obligation
-3.40%5.49M
-0.80%5.59M
-0.80%5.59M
11.86%5.7M
79.01%5.72M
78.98%5.68M
79.01%5.64M
79.01%5.64M
62.86%5.09M
3.00%3.2M
Current deferred liabilities
-58.43%360K
40.08%360K
40.08%360K
928.57%360K
--1.07M
--866K
-5.86%257K
-5.86%257K
-73.08%35K
--0
Current liabilities
61.36%43.4M
50.90%43.99M
50.90%43.99M
25.94%37.11M
78.72%34.68M
63.99%26.9M
53.81%29.15M
53.81%29.15M
62.23%29.47M
41.12%19.4M
Non current liabilities
Long term debt and capital lease obligation
-17.19%15.05M
-16.60%15.82M
-16.60%15.82M
-16.08%16.57M
65.93%17.36M
65.25%18.17M
64.63%18.97M
64.63%18.97M
64.10%19.74M
-16.50%10.46M
-Long term capital lease obligation
-17.19%15.05M
-16.60%15.82M
-16.60%15.82M
-16.08%16.57M
65.93%17.36M
65.25%18.17M
64.63%18.97M
64.63%18.97M
64.10%19.74M
-16.50%10.46M
Non current deferred liabilities
389.63%2.13M
-29.52%745K
-29.52%745K
-34.77%835K
-83.38%219K
-67.17%434K
8.74%1.06M
8.74%1.06M
16.79%1.28M
55.61%1.32M
Derivative product liabilities
14.91%370K
-12.68%358K
-12.68%358K
-12.88%345K
-12.57%334K
-12.74%322K
11.11%410K
11.11%410K
7.32%396K
80.19%382K
Other non current liabilities
-31.64%121K
-28.50%138K
-28.50%138K
-26.53%144K
-24.77%161K
-23.38%177K
-22.18%193K
-22.18%193K
880.00%196K
791.67%214K
Total non current liabilities
-7.55%17.67M
-17.29%17.06M
-17.29%17.06M
-17.22%17.89M
46.03%18.07M
47.89%19.11M
57.34%20.63M
57.34%20.63M
59.92%21.62M
-9.08%12.37M
Total liabilities
32.74%61.07M
22.64%61.05M
22.64%61.05M
7.67%55M
65.99%52.75M
56.89%46.01M
55.26%49.78M
55.26%49.78M
61.24%51.08M
16.15%31.78M
Shareholders'equity
Share capital
0.00%5K
20.00%6K
20.00%6K
0.00%5K
0.00%5K
0.00%5K
25.00%5K
25.00%5K
25.00%5K
25.00%5K
-common stock
0.00%5K
20.00%6K
20.00%6K
0.00%5K
0.00%5K
0.00%5K
25.00%5K
25.00%5K
25.00%5K
25.00%5K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-25.78%-785.06M
-24.32%-716.3M
-24.32%-716.3M
-39.73%-735.7M
-40.64%-678.83M
-39.41%-624.17M
-38.73%-576.2M
-38.73%-576.2M
-37.46%-526.52M
-29.48%-482.68M
Paid-in capital
13.12%1.24B
12.39%1.22B
12.39%1.22B
2.38%1.1B
2.62%1.1B
4.31%1.09B
50.26%1.09B
50.26%1.09B
51.37%1.08B
53.57%1.07B
Gains losses not affecting retained earnings
-154.22%-180K
217.47%727K
217.47%727K
-37.81%671K
215.02%337K
404.59%332K
1,331.25%229K
1,331.25%229K
102.06%1.08M
-184.93%-293K
Total stockholders'equity
-3.81%451.84M
-0.97%505.66M
-0.97%505.66M
-33.27%368.98M
-28.46%420.89M
-21.79%469.72M
65.87%510.61M
65.87%510.61M
67.59%552.95M
80.95%588.34M
Total equity
-3.81%451.84M
-0.97%505.66M
-0.97%505.66M
-33.27%368.98M
-28.46%420.89M
-21.79%469.72M
65.87%510.61M
65.87%510.61M
67.59%552.95M
80.95%588.34M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Assets
Current assets
Cash, cash equivalents and short term investments 21.61%390.89M-5.23%402.66M-5.23%402.66M-39.22%305.06M-45.89%293.23M-38.88%321.44M47.41%424.88M47.41%424.88M57.01%501.89M74.63%541.95M
-Cash and cash equivalents -45.71%72.49M-59.66%60.24M-59.66%60.24M-74.11%48.56M-59.19%77.16M-51.55%133.53M-40.05%149.34M-40.05%149.34M-31.97%187.54M-19.99%189.06M
-Short-term investments 69.44%318.4M24.27%342.41M24.27%342.41M-18.40%256.51M-38.77%216.07M-24.93%187.91M604.28%275.54M604.28%275.54M614.67%314.35M376.67%352.89M
Other current assets 30.04%14.47M4.22%10.48M4.22%10.48M-17.50%7.31M-5.85%10.06M14.99%11.13M20.33%10.06M20.33%10.06M3.33%8.87M43.78%10.69M
Total current assets 21.89%405.36M-5.01%413.13M-5.01%413.13M-38.84%312.38M-45.12%303.29M-37.91%332.57M46.65%434.93M46.65%434.93M55.60%510.76M73.91%552.63M
Non current assets
Net PPE -20.89%30.94M-18.71%33.01M-18.71%33.01M-15.78%35.06M26.16%37.15M27.91%39.12M28.24%40.61M28.24%40.61M27.35%41.63M-12.48%29.45M
-Gross PPE -5.74%53.49M-5.08%54.29M-5.08%54.29M-3.49%55.12M27.90%55.96M29.90%56.75M31.19%57.19M31.19%57.19M31.25%57.12M0.61%43.75M
-Accumulated depreciation -27.86%-22.55M-28.30%-21.28M-28.30%-21.28M-29.52%-20.06M-31.48%-18.8M-34.56%-17.64M-39.00%-16.59M-39.00%-16.59M-43.02%-15.49M-45.38%-14.3M
Investments and advances -51.29%66.74M38.22%111.38M38.22%111.38M37.69%67.17M246.65%123.81M117.67%137M635.65%80.58M635.65%80.58M--48.78M--35.72M
Other non current assets 39.97%9.86M115.63%9.19M115.63%9.19M227.51%9.38M304.74%9.39M813.49%7.04M522.95%4.26M522.95%4.26M319.94%2.86M114.81%2.32M
Total non current assets -41.29%107.54M22.42%153.58M22.42%153.58M19.66%111.61M152.43%170.35M94.24%183.16M189.71%125.45M189.71%125.45M179.51%93.27M94.33%67.48M
Total assets -0.55%512.91M1.13%566.71M1.13%566.71M-29.81%423.98M-23.62%473.64M-18.12%515.73M64.87%560.38M64.87%560.38M67.04%604.03M75.92%620.12M
Liabilities
Current liabilities
Payables 253.94%14.69M154.42%11.16M154.42%11.16M134.71%6.86M153.57%8.7M-1.57%4.15M24.78%4.39M24.78%4.39M-37.96%2.92M-1.77%3.43M
-accounts payable 253.94%14.69M154.42%11.16M154.42%11.16M134.71%6.86M153.57%8.7M-1.57%4.15M24.78%4.39M24.78%4.39M-37.96%2.92M-1.77%3.43M
Current accrued expenses 41.12%22.87M42.42%26.87M42.42%26.87M12.95%24.19M50.20%19.19M79.77%16.2M57.06%18.87M57.06%18.87M110.07%21.42M94.25%12.78M
Current debt and capital lease obligation -3.40%5.49M-0.80%5.59M-0.80%5.59M11.86%5.7M79.01%5.72M78.98%5.68M79.01%5.64M79.01%5.64M62.86%5.09M3.00%3.2M
-Current capital lease obligation -3.40%5.49M-0.80%5.59M-0.80%5.59M11.86%5.7M79.01%5.72M78.98%5.68M79.01%5.64M79.01%5.64M62.86%5.09M3.00%3.2M
Current deferred liabilities -58.43%360K40.08%360K40.08%360K928.57%360K--1.07M--866K-5.86%257K-5.86%257K-73.08%35K--0
Current liabilities 61.36%43.4M50.90%43.99M50.90%43.99M25.94%37.11M78.72%34.68M63.99%26.9M53.81%29.15M53.81%29.15M62.23%29.47M41.12%19.4M
Non current liabilities
Long term debt and capital lease obligation -17.19%15.05M-16.60%15.82M-16.60%15.82M-16.08%16.57M65.93%17.36M65.25%18.17M64.63%18.97M64.63%18.97M64.10%19.74M-16.50%10.46M
-Long term capital lease obligation -17.19%15.05M-16.60%15.82M-16.60%15.82M-16.08%16.57M65.93%17.36M65.25%18.17M64.63%18.97M64.63%18.97M64.10%19.74M-16.50%10.46M
Non current deferred liabilities 389.63%2.13M-29.52%745K-29.52%745K-34.77%835K-83.38%219K-67.17%434K8.74%1.06M8.74%1.06M16.79%1.28M55.61%1.32M
Derivative product liabilities 14.91%370K-12.68%358K-12.68%358K-12.88%345K-12.57%334K-12.74%322K11.11%410K11.11%410K7.32%396K80.19%382K
Other non current liabilities -31.64%121K-28.50%138K-28.50%138K-26.53%144K-24.77%161K-23.38%177K-22.18%193K-22.18%193K880.00%196K791.67%214K
Total non current liabilities -7.55%17.67M-17.29%17.06M-17.29%17.06M-17.22%17.89M46.03%18.07M47.89%19.11M57.34%20.63M57.34%20.63M59.92%21.62M-9.08%12.37M
Total liabilities 32.74%61.07M22.64%61.05M22.64%61.05M7.67%55M65.99%52.75M56.89%46.01M55.26%49.78M55.26%49.78M61.24%51.08M16.15%31.78M
Shareholders'equity
Share capital 0.00%5K20.00%6K20.00%6K0.00%5K0.00%5K0.00%5K25.00%5K25.00%5K25.00%5K25.00%5K
-common stock 0.00%5K20.00%6K20.00%6K0.00%5K0.00%5K0.00%5K25.00%5K25.00%5K25.00%5K25.00%5K
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -25.78%-785.06M-24.32%-716.3M-24.32%-716.3M-39.73%-735.7M-40.64%-678.83M-39.41%-624.17M-38.73%-576.2M-38.73%-576.2M-37.46%-526.52M-29.48%-482.68M
Paid-in capital 13.12%1.24B12.39%1.22B12.39%1.22B2.38%1.1B2.62%1.1B4.31%1.09B50.26%1.09B50.26%1.09B51.37%1.08B53.57%1.07B
Gains losses not affecting retained earnings -154.22%-180K217.47%727K217.47%727K-37.81%671K215.02%337K404.59%332K1,331.25%229K1,331.25%229K102.06%1.08M-184.93%-293K
Total stockholders'equity -3.81%451.84M-0.97%505.66M-0.97%505.66M-33.27%368.98M-28.46%420.89M-21.79%469.72M65.87%510.61M65.87%510.61M67.59%552.95M80.95%588.34M
Total equity -3.81%451.84M-0.97%505.66M-0.97%505.66M-33.27%368.98M-28.46%420.89M-21.79%469.72M65.87%510.61M65.87%510.61M67.59%552.95M80.95%588.34M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More